The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Mary - Scotland: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Mary from Scotland shares their ultiple sclerosis (MS) and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Martin - Wales: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Martin from Wales shares their Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Martha - US: Fibromyalgia (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Martha is from Hawaii in the United States, and takes low dose naltrexone (LDN) for fibromyalgia. Her first symptoms were a series of mysterious illnesses, stomach problems, fatigue, multiple chemical sensitivities, that in 2010 was diagnosed as fibromyalgia.
Mark - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Mark from England shares their multiple sclerosis (MS) and low dose naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Marjorie - Scotland: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Marjorie from Scotland shares their multiple sclerosis (MS) and low dose naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Marijke - Australia: Fibromyalgia (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Marijke from Australia shares her Fibromyalgia and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Marie - Sweden: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Marie from Sweden shares their multiple sclerosis (MS) and low dose naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Marie - England: Ankylosing Spondylitis (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Marie, who's originally from Germany and now from England, takes LDN for Ankylosing Spondylitis.